Literature DB >> 27908529

A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: Analysis of 37 cases.

Shiho Kuji1, Reiko Watanabe2, Yuichi Sato3, Takashi Iwata4, Yasuyuki Hirashima5, Munetaka Takekuma5, Ichiro Ito6, Masato Abe6, Ryo Nagashio3, Katsuhiro Omae7, Daisuke Aoki4, Toru Kameya6.   

Abstract

OBJECTIVE: High-grade neuroendocrine carcinoma of uterine cervix (HGNCUC) has been recognized as a highly malignant tumor. Therapeutic strategy specific to neuroendocrine (NE) tumors needs to be considered, but some cases wouldn't allow simple final diagnoses. Insulinoma-associated protein 1 (INSM1), which is a zinc-finger transcription factor related to NE differentiation, is frequently expressed in NE tumors. We investigated the association between INSM1 and HGNCUC, and the possibility of INSM1 as a useful NE marker.
METHODS: Thirty-seven cases of formalin-fixed and paraffin-embedded HGNCUCs were evaluated immunohistochemically for conventional NE markers and INSM1. We also surveyed polymerase chain reactions and examined the frequency and the genotype of human papillomavirus (HPV) infections.
RESULTS: In HGNCUC, chromogranin A, synaptophysin and neural cell adhesion molecule (NCAM) were expressed in 86%, 86% and 68%, respectively. In addition, INSM1 was detected in 95%. Positivity for INSM1 was clearly evaluated histologically, because the intensity of nuclear staining on positive cells was high and nonspecific reactions were minimal. In uni- and multivariate analyses of prognostic factors on stage I and II surgical cases, the association between INSM1 expression and prognosis was insignificant. We confirmed 72% of 29 examined cases had high risk HPV infections (type 16, 14%; type 18, 86%).
CONCLUSIONS: This study has clarified that INSM1 is closely related to the development of HGNCUC, and a useful new NE marker in conducting its correct and rapid diagnosis.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Cervical cancer; Human papillomavirus; INSM1; Insulinoma associated protein 1; Neuroendocrine carcinoma; Small cell carcinoma

Mesh:

Substances:

Year:  2016        PMID: 27908529     DOI: 10.1016/j.ygyno.2016.11.020

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  14 in total

Review 1.  Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?

Authors:  Andrew M Bellizzi
Journal:  Hum Pathol       Date:  2019-12-17       Impact factor: 3.466

Review 2.  Insulinoma-Associated-1: From Neuroendocrine Tumor Marker to Cancer Therapeutics.

Authors:  Chiachen Chen; Abner L Notkins; Michael S Lan
Journal:  Mol Cancer Res       Date:  2019-05-21       Impact factor: 5.852

3.  INSM1 Expression Is Frequent in Primary Central Nervous System Neoplasms but Not in the Adult Brain Parenchyma.

Authors:  Heather M Ames; Lisa M Rooper; John J Laterra; Charles G Eberhart; Fausto J Rodriguez
Journal:  J Neuropathol Exp Neurol       Date:  2018-05-01       Impact factor: 3.685

4.  INSM1 expression and its diagnostic significance in extraskeletal myxoid chondrosarcoma.

Authors:  Akihiko Yoshida; Naohiro Makise; Susumu Wakai; Akira Kawai; Nobuyoshi Hiraoka
Journal:  Mod Pathol       Date:  2018-01-12       Impact factor: 7.842

5.  Expression of Insulinoma-Associated Protein 1 (INSM1) and Orthopedia Homeobox (OTP) in Tumors with Neuroendocrine Differentiation at Rare Sites.

Authors:  Madhuchhanda Roy; Darya G Buehler; Ranran Zhang; Michael L Schwalbe; Rebecca M Baus; M Shahriar Salamat; Ricardo V Lloyd; Jason N Rosenbaum
Journal:  Endocr Pathol       Date:  2019-03       Impact factor: 3.943

6.  Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer.

Authors:  Kaushal Asrani; Alba Fc Torres; Juhyung Woo; Thiago Vidotto; Harrison K Tsai; Jun Luo; Eva Corey; Brian Hanratty; Ilsa Coleman; Srinivasan Yegnasubramanian; Angelo M De Marzo; Peter S Nelson; Michael C Haffner; Tamara L Lotan
Journal:  J Pathol       Date:  2021-09-23       Impact factor: 7.996

7.  A promoter-driven assay for INSM1-associated signaling pathway in neuroblastoma.

Authors:  Chiachen Chen; Michael S Lan
Journal:  Cell Signal       Date:  2020-09-20       Impact factor: 4.315

8.  Contribution of Human papillomavirus in neuroendocrine tumors from a series of 10,575 invasive cervical cancer cases.

Authors:  Maria Alejo; Laia Alemany; Omar Clavero; Beatriz Quiros; Susana Vighi; Muhieddine Seoud; Chou Cheng-Yang; Suzanne M Garland; Nuria Juanpere; Josep Lloreta; Sara Tous; Jo Ellen Klaustermeier; Wim Quint; F Xavier Bosch; Silvia de Sanjosé; Belen Lloveras
Journal:  Papillomavirus Res       Date:  2018-03-17

Review 9.  An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.

Authors:  Andrew M Bellizzi
Journal:  Adv Anat Pathol       Date:  2020-05       Impact factor: 4.571

10.  Neuroendocrine carcinoma of the cervix: a systematic review of the literature.

Authors:  Clemens B Tempfer; Iris Tischoff; Askin Dogan; Ziad Hilal; Beate Schultheis; Peter Kern; Günther A Rezniczek
Journal:  BMC Cancer       Date:  2018-05-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.